XL019

XL019 Basic information
Product Name:XL019
Synonyms:2S)-N-[4-[2-[[4-(4-Morpholinyl)phenyl]amino]-4-pyrimidinyl]phenyl]-2-pyrrolidinecarboxamide XL019;XL019 2-Pyrrolidinecarboxamide, N-[4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]phenyl]-, (2S)-;Pyrrolidine-2-carboxylic acid {4-[2-(4-morpholin-4-yl-phenylamino)-pyrimidin-4-yl]-phenyl}-amide;XL019, >=98%;XL019, >95%;XL019; XL-019; XL 019.;XL019;XL019/XL-019
CAS:945755-56-6
MF:C25H28N6O2
MW:444.53
EINECS:
Product Categories:JAK;Inhibitors;STAT
Mol File:945755-56-6.mol
XL019 Structure
XL019 Chemical Properties
storage temp. Store at -20°C
solubility insoluble in EtOH; insoluble in H2O; ≥11.125 mg/mL in DMSO
form solid
Safety Information
MSDS Information
XL019 Usage And Synthesis
UsesXL019 is used in the synthesis of JAK-2 modulators for the treatment of related diseases.
targetJAK2
XL019 Preparation Products And Raw materials
XL147 XL 228 XL-019 Tofacitinib 3-(3,4-Difluorobenzoyl)-1,2,3,6-tetrahydro-1,1-dimethylazepino[4,5-b]indole-5-carboxylic acid 1-methylethyl ester Trametinib XL-388 Paclitaxel XL888 BMS 833923 Saracatinib Cabozantinib pilaralisib Baricitinib 2-methoxyethyl 4-((4-(4-chlorophenoxy)-3,5-difluorophenyl)sulfonyl)-3-(hydroxycarbamoyl)piperazine-1-carboxylate BMS-852927 Tofacitinib citrate XL413 (BMS-863233)

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.